Prioritizing Cardiovascular Disease-Associated Variants Altering NKX2-5 Binding through an Integrative Computational Approach
Edwin G. Peña-MartíneziD, Diego A. Pomales-MatosiD, Alejandro Rivera-MaderaiD, Jean L. Messon-BirdiD, Joshua G. Medina-FelicianoiD, Leandro Sanabria-AlbertoiD, Adriana C. Barreiro-RosarioiD, Jessica M. Rodríguez-RíosiD, José A. Rodríguez‐MartíneziD
Abstract
Cardiovascular diseases (CVDs) are the leading cause of death worldwide and are heavily influenced by genetic factors. Genome-wide association studies (GWAS) have mapped > 90% of CVD-associated variants within the non-coding genome, which can alter the function of regulatory proteins, like transcription factors (TFs). However, due to the overwhelming number of GWAS single nucleotide polymorphisms (SNPs) (>500,000), prioritizing variants for in vitro analysis remains challenging. In this work, we implemented a computational approach that considers support vector machine (SVM)-based TF binding site classification and cardiac expression quantitative trait loci (eQTL) analysis to identify and prioritize potential CVD-causing SNPs. We identified 1,535 CVD-associated SNPs that occur within human heart footprints/enhancers and 9,309 variants in linkage disequilibrium (LD) with differential gene expression profiles in cardiac tissue. Using hiPSC-CM ChIP-seq data from NKX2-5 and TBX5, two cardiac TFs essential for proper heart development, we trained a large-scale gapped k-mer SVM (LS-GKM-SVM) predictive model that can identify binding sites altered by CVD-associated SNPs. The computational predictive model was tested by scoring human heart footprints and enhancers in vitro through electrophoretic mobility shift assay (EMSA). Three variants (rs59310144, rs6715570, and rs61872084) were prioritized for in vitro validation based on their eQTL in cardiac tissue and LS-GKM-SVM prediction to alter NKX2-5 DNA binding. All three variants altered NKX2-5 DNA binding. In summary, we present a bioinformatic approach that considers tissue-specific eQTL analysis and SVM-based TF binding site classification to prioritize CVD-associated variants for in vitro experimental analysis. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=55 SRC="FIGDIR/small/23294951v1_ufig1.gif" ALT="Figure 1"> View larger version (18K): org.highwire.dtl.DTLVardef@d12742org.highwire.dtl.DTLVardef@1687d3forg.highwire.dtl.DTLVardef@f6d7b9org.highwire.dtl.DTLVardef@1ccc18a_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cardiovascular Disease-Associated Non-Coding Variants Disrupt GATA4-DNA Binding and Regulatory Functions
Edwin G. Peña-Martínez, Jean L. Messon-Bird, … José A. Rodríguez‐Martínez·Human Genetics and Genomics AdvancesPeer-reviewed·Feb 12, 2025
- Global Evaluation of Congenital Heart Disease-Associated Non-Coding Variants
Edwin G. Peña-Martínez, Edwin Peña-Martínez, … Devesh Bhimsaria·bioRxiv·Dec 10, 2025
- Disease-Associated Non-Coding Variants Alter NKX2-5 DNA-Binding Affinity
E. G. Pena-Martinez, A. Rivera-Madera, … J. A. Rodriguez-Martinez·bioRxiv·Dec 2, 2022
- CVD-associated SNPs with regulatory potential drive pathologic non-coding RNA expression
Chaonan Zhu, Nina Baumgarten, … Jaya Krishnan·Human GenomicsPeer-reviewed·Jul 25, 2023
- Allele-specific NKX2-5 binding underlies multiple genetic associations with human EKG traits
Paola Benaglio, Agnieszka D’Antonio‐Chronowska, … Kelly A. Frazer·Nature GeneticsPeer-reviewed·Sep 30, 2019
- Fine mapping spatiotemporal mechanisms of genetic variants underlying cardiac traits and disease
Matteo D’Antonio, Jennifer Nguyen, … Agnieszka D’Antonio‐Chronowska·Nature CommunicationsPeer-reviewed·Feb 28, 2023